Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shockwave Therapy for Plantar Fasciitis RCT

NCT: NCT04332471 · ACTIVE_NOT_RECRUITING

NCT IDNCT04332471
StatusACTIVE_NOT_RECRUITING
Start Date2020-06-01
Completion2027-03-01

Brief Summary

Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several studies have compared the effects of different types of extracorporeal shockwave therapy (radial and focused) with other forms of conservative treatment in patients with chronic plantar fasciitis. No study has yet compared the effect of radial vs. focused shockwave therapy on pain in this population.

Frequently Asked Questions

What is Shockwave Therapy for Plantar Fasciitis RCT?

Shockwave Therapy for Plantar Fasciitis RCT is a clinical trial registered under NCT04332471. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04332471?

The current status of NCT04332471 (Shockwave Therapy for Plantar Fasciitis RCT) is: ACTIVE_NOT_RECRUITING.

When did Shockwave Therapy for Plantar Fasciitis RCT start?

Shockwave Therapy for Plantar Fasciitis RCT started on 2020-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.